RACHAEL CREWS: Open Payments
NPI 1881371045 · STATESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$441 in 20 payments from 8 companies in 2025. Trend: 2023 $245 · 2024 $529 · 2025 $441
Food & beverage: $441
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $110 |
| Calliditas Therapeutics US Inc. | 4 | $105 |
| Ardelyx, Inc. | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Novo Nordisk Inc | 2 | $43 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $34 |
| Amgen Inc. | 1 | $24 |
| Lilly USA, LLC | 1 | $14 |
Products named: Fabhalta, TARPEYO, IBSRELA, FARXIGA, Kerendia, Ozempic, KRYSTEXXA, Wegovy.
Industry payments across NC — which companies pay providers there.
